REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q1 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,362,141 | -10.0% | 325,768 | +9.3% | 0.00% | 0.0% |
| Q2 2023 | $5,960,578 | +8.8% | 298,178 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $5,476,469 | -16.0% | 289,607 | +0.7% | 0.00% | 0.0% |
| Q4 2022 | $6,522,020 | -11.5% | 287,567 | +3.1% | 0.00% | -33.3% |
| Q3 2022 | $7,370,000 | +8.7% | 278,828 | +1.6% | 0.00% | +50.0% |
| Q2 2022 | $6,778,000 | -28.9% | 274,397 | -4.5% | 0.00% | -33.3% |
| Q1 2022 | $9,535,000 | +1.2% | 287,286 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $9,426,000 | -21.0% | 288,238 | +1.2% | 0.00% | -25.0% |
| Q3 2021 | $11,935,000 | +15.8% | 284,700 | +7.3% | 0.00% | +33.3% |
| Q2 2021 | $10,305,000 | +22.9% | 265,229 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $8,385,000 | -10.5% | 245,822 | +19.0% | 0.00% | -25.0% |
| Q4 2020 | $9,367,000 | +66.9% | 206,494 | +1.3% | 0.00% | +33.3% |
| Q3 2020 | $5,611,000 | -29.4% | 203,869 | -5.5% | 0.00% | -25.0% |
| Q2 2020 | $7,949,000 | +21.0% | 215,817 | +6.3% | 0.00% | 0.0% |
| Q1 2020 | $6,572,000 | -18.7% | 202,960 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $8,079,000 | +17.8% | 197,176 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $6,860,000 | -28.1% | 192,693 | +3.7% | 0.00% | -33.3% |
| Q2 2019 | $9,546,000 | -20.4% | 185,824 | -11.2% | 0.01% | -25.0% |
| Q1 2019 | $11,990,000 | +48.1% | 209,208 | +8.4% | 0.01% | +33.3% |
| Q4 2018 | $8,097,000 | -42.5% | 193,009 | +3.5% | 0.01% | -33.3% |
| Q3 2018 | $14,082,000 | +36.1% | 186,515 | +29.3% | 0.01% | +12.5% |
| Q2 2018 | $10,347,000 | +156.6% | 144,208 | +6.7% | 0.01% | +166.7% |
| Q1 2018 | $4,033,000 | -5.4% | 135,094 | +5.4% | 0.00% | 0.0% |
| Q4 2017 | $4,263,000 | +5.6% | 128,187 | +4.6% | 0.00% | -25.0% |
| Q3 2017 | $4,037,000 | +109.2% | 122,509 | +25.4% | 0.00% | +100.0% |
| Q2 2017 | $1,930,000 | +35.6% | 97,695 | +32.5% | 0.00% | +100.0% |
| Q1 2017 | $1,423,000 | +10.4% | 73,724 | +6.2% | 0.00% | 0.0% |
| Q4 2016 | $1,289,000 | +40.1% | 69,449 | +5.9% | 0.00% | 0.0% |
| Q3 2016 | $920,000 | +181.3% | 65,599 | +60.9% | 0.00% | – |
| Q2 2016 | $327,000 | +31.3% | 40,778 | +77.4% | 0.00% | – |
| Q1 2016 | $249,000 | -33.8% | 22,984 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $376,000 | – | 22,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |